Cartesian Therapeutics reports sustained benefits of Descartes-08 CAR-T therapy in generalized myasthenia gravis patients, ...
A scrappy team of drug developers has come together to create new medicines for patients with autoimmune diseases and allergies. They're going after the bustling subfield of Graves' disease and ...
A congressional commission is calling for at least a $15 billion federal investment in America’s biotechnology sector, ...
The Trump administration will hike payments to Medicare Advantage insurers by more than $25 billion next year, according to ...
The government said it 'may consider future policy options' for anti-obesity medications, after declining to finalize a Biden ...
A federal judge in Minnesota knocked down challenges from two drugmakers against a state law that the companies argued overly expanded the scope of the government's 340B drug discount program.
PureTech Health, a Boston biopharma company that has created drug developers like Karuna Therapeutics and Seaport ...
Amy Comstock Rick joined the FDA last November, and she not only survived the widespread staff cuts last week, she’s one of only a handful … Get free access to a limited number of articles, ...
To make sense of the stock selloff that started late last week, Endpoints News’ Max Bayer and Drew Armstrong spoke to Leerink ...
Pharma tool and packaging production companies are readying themselves for direct impact from President Donald Trump’s ...
The fallout comes amid a yearslong slog for biotech, which has struggled since high interest rates and inflation curbed what ...
RayThera has collected $110 million in a Series A raise to help it advance a preclinical pipeline of small molecule drugs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback